Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-03-28

Clinical Trial Update: Study Comparing Perceptions and Satisfaction for Two Different Delivery Mechanisms for Etanercept [Phase 3]

View source ↗

Summary

Phase 3 study comparing two delivery mechanisms for etanercept in rheumatoid arthritis has completed and posted results. The trial evaluated patient perceptions…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ENBREL (etanercept)

Snippet

Sponsor: Pfizer | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2013-03-28